Publicaciones en colaboración con investigadores/as de Universidad de Salamanca (11)

2024

  1. A Missense Variant in TP53 Could Be a Genetic Biomarker Associated with Bone Tissue Alterations

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial

    Journal of Bone and Mineral Research, Vol. 38, Núm. 4, pp. 471-479

2022

  1. Association between genetic variants in oxidative stress-related genes and osteoporotic bone fracture. The Hortega follow-up study

    Gene, Vol. 809

  2. Genetic variants in obesity-related genes and the risk of osteoporotic fracture. The Hortega Follow-up Study

    Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 1, pp. 32

  3. Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women

    Journal of Bone and Mineral Research

2021

  1. Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial

    Journal of Bone and Mineral Research, Vol. 36, Núm. 10, pp. 1967-1978

2020

  1. Polymorphisms in genes involved in inflammation, the NF-kB pathway and the renin-angiotensin-aldosterone system are associated with the risk of osteoporotic fracture. The Hortega Follow-up Study

    Bone, Vol. 138

2010

  1. Vitamin D levels and lipid response to atorvastatin

    International Journal of Endocrinology, Vol. 2010

2008

  1. Association of aromatase and estrogen receptor gene polymorphisms with hip fractures

    Osteoporosis International, Vol. 19, Núm. 6, pp. 787-792

2000

  1. Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells

    Neuroendocrinology, Vol. 72, Núm. 3, pp. 187-194

1992

  1. Opioids depress in vitro human monocyte chemotaxis

    Immunopharmacology, Vol. 23, Núm. 1, pp. 57-61